CM
RETA

Caption Management’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Caption Management’s Portfolio RETA Stock Details RETA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-81,400
Closed -$8.3M – 1635
2023
Q2 		$8.3M Sell
81,400
-445,800
-85% -$42.2M 0.15% 171
2023
Q1 		$47.9M Buy
+527,200
New +$30.9M 0.93% 12
2022
Q4 		– Sell
-275,000
Closed -$6.91M – 1847
2022
Q3 		$6.91M Buy
+275,000
New +$7.62M 0.1% 260
2022
Q2 		– Sell
-15,000
Closed -$492K – 1960
2022
Q1 		$492K Buy
+15,000
New +$445K 0.01% 1143
2020
Q4 		– Sell
-16,800
Closed -$1.64M – 1309
2020
Q3 		$1.64M Buy
16,800
+1,800
+12% +$225K 0.04% 498
2020
Q2 		$2.34M Sell
15,000
-60,400
-80% -$9.18M 0.08% 335
2020
Q1 		$10.9M Buy
75,400
+200
+0.3% +$38.6K 0.62% 22
2019
Q4 		$15.4M Buy
75,200
+40,200
+115% +$7.33M 0.52% 35
2019
Q3 		$2.81M Buy
35,000
+25,000
+250% +$2.12M 0.15% 183
2019
Q2 		$943K Buy
+10,000
New +$863K 0.05% 383

Other funds holding RETA

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Caption Management's RETA Position: Q4 2022 in Review

Caption Management sold out of Reata Pharmaceuticals, Inc. Class A Common Stock (RETA) in Q4 2022, closing a stake of 56,010 shares — an estimated $1.41M sold.

Caption Management first reported a position in RETA in Q4 2019 and held it in 6 quarters. The position peaked at $7.24M in Q4 2019. 168 funds tracked by Wall St. Rank hold RETA as of Q4 2022.

  • Caption Management reported no remaining Reata Pharmaceuticals, Inc. Class A Common Stock position as of Q4 2022 after selling out during the quarter.
  • Caption Management sold 56,010 Reata Pharmaceuticals, Inc. Class A Common Stock shares in Q4 2022, an estimated $1.41M.
  • Caption Management first reported a position in Reata Pharmaceuticals, Inc. Class A Common Stock in Q4 2019 and held it in 6 quarters.
  • Caption Management's Reata Pharmaceuticals, Inc. Class A Common Stock position peaked at $7.24M in Q4 2019.
  • 168 funds tracked by Wall St. Rank held Reata Pharmaceuticals, Inc. Class A Common Stock as of Q4 2022.

Based on Caption Management's 13F filing for Q4 2022, filed 14 Feb 2023.